These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23781590)

  • 1. The value of mesothelin in the diagnosis and follow-up of surgically treated ovarian cancer.
    Qiao N; Li H
    Eur J Gynaecol Oncol; 2013; 34(2):163-5. PubMed ID: 23781590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum mesothelin in malignant and benign ovarian masses.
    Ibrahim M; Bahaa A; Ibrahim A; El Hakem AA; Abo-El Noor A; El Tohamy U
    Arch Gynecol Obstet; 2014 Jul; 290(1):107-13. PubMed ID: 24445964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.
    Wu X; Li D; Liu L; Liu B; Liang H; Yang B
    Arch Gynecol Obstet; 2014 Jun; 289(6):1309-14. PubMed ID: 24370956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mesothelin in ovarian cancer].
    Fraszczak K; Barczyński B; Polak G; Kułak K; Kotarski J
    Pol Merkur Lekarski; 2013 Sep; 35(207):166-70. PubMed ID: 24224456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor.
    Huang CY; Cheng WF; Lee CN; Su YN; Chien SC; Tzeng YL; Hsieh CY; Chen CA
    Anticancer Res; 2006; 26(6C):4721-8. PubMed ID: 17214332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancer.
    Aktas B; Kasimir-Bauer S; Wimberger P; Kimmig R; Heubner M
    Anticancer Res; 2013 Jan; 33(1):329-36. PubMed ID: 23267165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.
    Hassan R; Remaley AT; Sampson ML; Zhang J; Cox DD; Pingpank J; Alexander R; Willingham M; Pastan I; Onda M
    Clin Cancer Res; 2006 Jan; 12(2):447-53. PubMed ID: 16428485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
    Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
    Lin JY; Qin JB; Li XY; Dong P; Yin BD
    Asian Pac J Cancer Prev; 2012; 13(11):5427-32. PubMed ID: 23317195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.
    Bandiera E; Zanotti L; Fabricio AS; Bucca E; Squarcina E; Romani C; Tassi R; Bignotti E; Todeschini P; Tognon G; Romagnolo C; Gion M; Sartori E; Maggino T; Pecorelli S; Ravaggi A
    Clin Chem Lab Med; 2013 Sep; 51(9):1815-24. PubMed ID: 24013103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to mesothelin in infertility.
    Luborsky JL; Yu Y; Edassery SL; Jaffar J; Yip YY; Liu P; Hellstrom KE; Hellstrom I
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1970-8. PubMed ID: 21846819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?
    Creaney J; Yeoman D; Musk AW; de Klerk N; Skates SJ; Robinson BW
    Lung Cancer; 2011 Oct; 74(1):55-60. PubMed ID: 21397972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
    Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
    Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients.
    Hellstrom I; Friedman E; Verch T; Yang Y; Korach J; Jaffar J; Swisher E; Zhang B; Ben-Baruch G; Tan MC; Goedegebuure P; Hellstrom KE
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1520-6. PubMed ID: 18559570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better Predictive Value of Cancer Antigen125 (CA125) as Biomarker in Ovary and Breast Tumors and its Correlation with the Histopathological Type/Grade of the Disease.
    Nazmeen A; Maiti S; Mandal K; Roy SK; Ghosh TK; Sinha NK; Mandal K
    Med Chem; 2017; 13(8):796-804. PubMed ID: 28440189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of Ki-67, E-cadherin, and mesothelin in serous borderline ovarian tumor.
    Yu N; Wang N; Liu YF; Li YY; Zhang TG
    Eur J Gynaecol Oncol; 2017; 38(1):85-90. PubMed ID: 29767871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of mesothelin in occupational medicine practice.
    Smolková P; Nakládalová M; Zapletalová J; Jakubec P; Vildová H; Kolek V; Petřek M; Nakládal Z
    Int J Occup Med Environ Health; 2016; 29(3):395-404. PubMed ID: 26988879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions.
    Hooper CE; Morley AJ; Virgo P; Harvey JE; Kahan B; Maskell NA
    Eur Respir J; 2013 Jan; 41(1):18-24. PubMed ID: 22790919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.